Top Value Effervescent Pain Relief
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Top Value Effervescent Pain Relief
- Generic name
- ASPIRIN, CITRIC ACID, SODIUM BICAROBONATE
- Manufacturer
- Tower Laboratories Ltd
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 44babed8-cf38-1c12-e054-00144ff8d46c
- SPL ID
- 2902dd3f-009e-6c01-e063-6294a90ae261
- Version
- 6
- Effective date
- 2024-12-11
- Source export date
- 2026-09-28
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:37:00
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M013 | openfda.application_number | |
| brand name | Top Value Effervescent Pain Relief | openfda.brand_name | |
| generic name | ASPIRIN, CITRIC ACID, SODIUM BICAROBONATE | openfda.generic_name | |
| manufacturer name | Tower Laboratories Ltd | openfda.manufacturer_name | |
| ndc | package | 50201-4213-6 | openfda.package_ndc |
| ndc | product | 50201-4213 | openfda.product_ndc |
| ndc11 | package | 50201421306 | derived:openfda.package_ndc |
| rxcui | 1536675 | openfda.rxcui | |
| spl id | 2902dd3f-009e-6c01-e063-6294a90ae261 | id | |
| spl set id | 44babed8-cf38-1c12-e054-00144ff8d46c | set_id | |
| unii | R16CO5Y76E | openfda.unii | |
| unii | XF417D3PSL | openfda.unii | |
| unii | 8MDF5V39QO | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Allergy alert: Aspirin may cause a severe allergic reaction which may include: ■ hives ■ facial swelling ■ asthma (wheezing) ■ shock Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause severe stomach bleeding. The chance is higher if you ■ are age 60 or older ■ have had stomach ulcers or bleeding problems ■ take a blood thinning (anticoagulant) or steroid drug ■ take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) ■ have 3 or more alcoholic drinks every day while using this product ■ take more or for a longer time than directed
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Serious side effects associated with the use of this product can be reported to the following address: Tower Laboratories LTD P.O. Box 306 8 Industrial Park Road Centerbrook, CT 06409
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.